Tofacitinib Citrate for the Treatment of Nail Dystrophy Associated With Alopecia Universalis
April 2016
in “JAMA Dermatology”
TLDR Tofacitinib citrate improved nail dystrophy and pain in patients with alopecia universalis without causing side effects.
The document reports on the use of tofacitinib citrate, a Janus kinase (JAK) inhibitor, for treating nail dystrophy in three patients with alopecia universalis (AU). The patients, two men in their 20s and one woman in her 40s, were treated with tofacitinib at doses of 5 mg twice daily, with one patient increasing to 10 mg in the morning and 5 mg at night after two months. Over a period of 5 to 6 months, all three patients experienced remission of nail changes and associated discomfort or pain. Two of the patients also experienced hair growth, although one did not. The treatment was well tolerated, with no observed side effects such as infections, cytopenias, transaminitis, decreased renal function, or increased lipid levels. The study suggests that tofacitinib and other JAK inhibitors may be effective in treating severe nail dystrophy associated with AA and its variants, but additional studies are needed to confirm efficacy and safety.
View this study on doi.org →
Cited in this study
research Successful hair regrowth in a Korean patient with alopecia universalis following tofacitinib treatment
A Korean woman with complete hair loss regrew her hair after taking tofacitinib, with no side effects.
research Reversal of Alopecia Areata Following Treatment With the JAK1/2 Inhibitor Baricitinib
A patient with Alopecia Areata had complete hair regrowth after using the drug baricitinib.
research Killing Two Birds with One Stone: Oral Tofacitinib Reverses Alopecia Universalis in a Patient with Plaque Psoriasis
A man with severe hair loss and skin disease regrew his hair with no side effects after taking tofacitinib.
research Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition
Alopecia areata can be reversed by JAK inhibitors, promoting hair regrowth.
Related
research The Usefulness and Wellbeing of Tofacitinib in the Treatment of Alopecia Areata
Tofacitinib is effective and safe for treating alopecia areata.
research Treatment of Longstanding Alopecia Areata Universalis of the Eyebrows/Facial Hair with Oral and Topical Tofacitinib
Oral and topical tofacitinib can effectively treat severe hair loss with minimal side effects.
research Successful Treatment of Severe Alopecia Areata With Oral or Topical Tofacitinib.
Oral and topical tofacitinib can help regrow hair in people with severe alopecia areata.
research Topical 2% tofacitinib for children with alopecia areata, alopecia totalis, and alopecia universalis
Applying 2% tofacitinib cream helped some children with severe hair loss grow back hair.
research Nail involvement in patients with moderate-to-severe alopecia areata treated with oral tofacitinib
Tofacitinib improves nail conditions in patients with severe hair loss and does not affect hair regrowth.
research Successful Treatment of Refractory Alopecia Areata Universalis and Psoriatic Arthritis, But Not of Plaque Psoriasis with Tofacitinib in a Young Woman
Tofacitinib helped a young woman's severe hair loss and arthritis but not her plaque psoriasis.